scorecardresearch
Tuesday, July 22, 2025
TopicPfizer

Topic: Pfizer

Pfizer asks US FDA to authorise Covid booster shots for all adults

Pfizer submitted data from a large trial showing that an additional dose is highly effective at preventing infection.

UK reduces booking time for Covid booster shots by a month to ramp up vaccine rollout

All aged above 50 years and those at most risk from Covid will be able to book their appointment after five months rather than waiting for six months.

Falsified data, inadequately trained vaccinators: BMJ flags Pfizer vaccine trial ‘violations’

An estimated 418.41 million doses of the Pfizer vaccine have been administered across the world, as of 3 November. India hasn’t given approval to the vaccine.

US authorises Pfizer Covid vaccine for children aged 5 to 11

President Joe Biden’s administration has said they have enough vaccines for all 28 million kids in the 5 to 11 age group, and they are ready to ship the shots.

Beijing delay in approving Pfizer-BioNTech shot raises questions on China’s vaccination plans

Analysts say Beijing's concern might be that approval of the BioNTech shot could be interpreted as an acknowledgment that local shots are less effective than western ones.

US regulators grant full approval to Pfizer-BioNTech Covid vaccine for those aged 16 & above

The approval is the first for a Covid vaccine. The two-dose regimen was initially made available in the U.S. through an emergency authorization late last year.

Study indicates Alpha variant could be causing higher breakthrough infections than expected

Researchers said the healthcare workers with breakthrough infections had mild symptoms but high viral loads & were shedding the virus up to 32 days after diagnosis.

Israel govt data shows Pfizer vaccine’s efficacy could be diminishing in preventing infection

Israel’s national health data shows sharp fall in effectiveness of Pfizer vaccine from 95% in Jan-April to 39% in June-July. Researchers, however, advise caution as study size is small.

8-10 week gap between Pfizer doses boosts antibodies, UK study says

The study said neutralising antibody levels were twice as high after the 10-week interval as with the three-week span.

Mixing vaccines without evidence a ‘dangerous’ trend, WHO’s Soumya Swaminathan says

Swaminathan warned that it will be a chaotic situation in countries if citizens start deciding ‘when and who should be taking a second, third or fourth dose’.

On Camera

Bihar mimics 19th-century American South. Citizenship is now weaponised to exclude voters

Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.